Bioregulator - Start
Bioregulator - Start Original price was: $188.99.Current price is: $160.99.
Back to products

Bioregulator – Advanced

Original price was: $390.99.Current price is: $292.99.

Multi-component research reference set
Out of stock

Temporarily unavailable. Leave your details and we will let you know the moment it is back.

Bioregulator (Advanced) - Multi-Component Research Reference Set

FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.

Component list of Bioregulator (Advanced) - Multi-Component Research Reference Set
Components of this multi-component item; each is documented and supplied separately.

Analytical Identity

Identity & nomenclature
Set typeMulti-component research reference set
Number of components6
ComponentsThymalin; Pinealon; Vesugen; Cartalax; Cardiogen; Cortagen
Physicochemical
AppearanceLyophilized powders in individual sealed vials
Quality & provenance
PurityEach component not less than 98% by HPLC (see per-component Certificate of Analysis)
SourceSynthetic
Catalog / SKUSTACK-BIOREG-ADV

Bioregulator (Advanced) is supplied as a multi-component laboratory research reference set intended strictly for in-vitro and laboratory research use. The set (catalog STACK-BIOREG-ADV) consolidates six individually documented short-peptide reference materials into a single kit format, enabling parallel analytical work, comparative identity confirmation, and method development without the sourcing overhead of assembling each item separately.

The six components included in the Bioregulator (Advanced) set are Thymalin, Pinealon, Vesugen, Cartalax, Cardiogen, and Cortagen. All six are synthetic short-chain peptides belonging to the broader family of oligopeptide research materials frequently referenced in the chemical and biochemical literature originating from Russian peptide chemistry programs. Each is prepared by solid-phase synthesis and supplied as a lyophilized (freeze-dried) powder in its own sealed vial, allowing investigators to select, weigh, and reconstitute individual components independently under their own validated protocols.

Analytical documentation is component-specific. Each vial in the Bioregulator (Advanced) set is released against a lot-specific Certificate of Analysis reporting a purity of not less than 98% by reversed-phase HPLC, along with identity confirmation appropriate to the material. This per-component CoA structure is intended to support use as a laboratory reference standard for chromatographic retention comparisons, mass-spectrometric identity checks, stability and forced-degradation studies, assay qualification, and cross-lot analytical benchmarking.

From a formulator and handling perspective, the lyophilized presentation is chosen to maximize dry-state shelf life and to give the researcher full control over solvent selection, buffer composition, ionic strength, and working concentration during reconstitution. Because the six peptides differ in sequence length, isoelectric behavior, and solubility profile, PEPTIDE.Power supplies them as discrete single-analyte vials rather than as a premixed blend, preserving the analytical integrity of each component.

PEPTIDE.Power makes no therapeutic, diagnostic, prophylactic, or efficacy claims regarding the Bioregulator (Advanced) set or any of its individual components, and provides no administration, combination, sequencing, or dosing guidance of any kind. The materials in this set are not drugs, dietary supplements, cosmetics, or food, and are not intended for human or veterinary use, injection, ingestion, topical application, or any form of in-vivo administration. Identity and purity of each of the six components are documented solely on the corresponding lot-specific Certificate of Analysis, which is available on request and constitutes the authoritative record for the material shipped.

Physical format

Supplied as a set of individually sealed vials of lyophilized (freeze-dried) powder, one per component. A research reference set - not a finished product and not a delivery device. Net contents per component are shown in the product options.

Certificate of Analysis

DocumentationPer-component lot-specific Certificate of Analysis
ComponentsThymalin; Pinealon; Vesugen; Cartalax; Cardiogen; Cortagen
IdentityEach component confirmed by HPLC and mass spectrometry

Lot-specific COA available — contact [email protected] with your lot number.

Storage & handling

Store each sealed lyophilized component at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; Safety Data Sheets (SDS) are available on request.

Eligibility & terms of sale

This set is sold to qualified laboratory and research buyers for lawful research use only. The components are not drugs, supplements, cosmetics, or food, and are not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use these materials only for lawful laboratory research.

FAQ

What is in this set?
6 individually packaged research reference materials: Thymalin, Pinealon, Vesugen, Cartalax, Cardiogen, and Cortagen. Net contents per component are shown in the product options.

How is purity verified?
Each component is documented not less than 98% by HPLC; a per-component Certificate of Analysis lists the lot-specific result.

Can you advise on combining, dosing, or administering these materials?
No. We provide batch documentation, storage, and handling information only; we do not provide combination, dosing, reconstitution, administration, or therapeutic guidance.

Is lot-specific documentation available?
Yes - contact [email protected] with your lot numbers for the Certificate of Analysis of each component.

Related reference materials

Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.